Literature DB >> 21459993

The assessment of symptom severity and functional impairment with DSM-IV axis V.

Geoffrey Norman Smith1, Thomas S Ehmann, Sean W Flynn, G William MacEwan, Karen Tee, Lili C Kopala, Allen E Thornton, Christian H Schenk, William G Honer.   

Abstract

OBJECTIVE: The Global Assessment of Functioning scale (GAF) is included as axis V in the DSM-IV multiaxial diagnostic system. The GAF is simple to administer and routinely used in treatment planning and as a measure of program performance. The GAF assesses both symptom severity and functional impairment, but the resultant rating provides no information about the contribution of each of these domains. This study aimed to improve the clinical utility of the GAF by creating subscales.
METHODS: The authors divided the scale into its two principal domains: descriptors of social and occupational functioning (SOFAS) and descriptors of symptoms (GAF minus SOFAS descriptors). These and other measures of symptoms and functioning were used to assess 407 patients while acutely psychotic and again after treatment.
RESULTS: Symptom scores were of greater severity than functional impairment scores in most cases. Because of this, the GAF score tended to reflect symptom severity rather than functional impairment. The symptom rating was more strongly correlated with measures of positive symptoms, and the functional rating had higher associations with negative symptoms and functional impairment. Both scales were good indicators of clinical change.
CONCLUSIONS: Findings indicate that GAF ratings for patients with psychosis tend to reflect symptom severity rather than functional impairment. Splitting the GAF into two parts resulted in greater discrimination for this patient group yet retained ease of administration.

Entities:  

Mesh:

Year:  2011        PMID: 21459993     DOI: 10.1176/ps.62.4.pss6204_0411

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  8 in total

1.  Assessment of clinical information: Comparison of the validity of a Structured Clinical Interview (the SCID) and the Clinical Diagnostic Interview.

Authors:  Rebecca Drill; Ora Nakash; Jared A DeFife; Drew Westen
Journal:  J Nerv Ment Dis       Date:  2015-06       Impact factor: 2.254

2.  Diagnoses, intervention strategies, and rates of functional improvement in integrated behavioral health care patients.

Authors:  Ana J Bridges; Samantha J Gregus; Juventino Hernandez Rodriguez; Arthur R Andrews; Bianca T Villalobos; Freddie A Pastrana; Timothy A Cavell
Journal:  J Consult Clin Psychol       Date:  2015-03-16

3.  Impact of adaptive functioning on readmission to alcohol detoxification among Alaska Native People.

Authors:  Ursula Running Bear; Heather Anderson; Spero M Manson; Jay H Shore; Allan V Prochazka; Douglas K Novins
Journal:  Drug Alcohol Depend       Date:  2014-04-28       Impact factor: 4.492

4.  Collecting Information for Rating Global Assessment of Functioning (GAF): Sources of Information and Methods for Information Collection.

Authors:  Monrad Aas I H
Journal:  Curr Psychiatry Rev       Date:  2014-11

5.  Experiences, perspectives and priorities of people with schizophrenia spectrum disorders regarding sleep disturbance and its treatment: a qualitative study.

Authors:  Sophie Faulkner; Penny Bee
Journal:  BMC Psychiatry       Date:  2017-05-02       Impact factor: 3.630

6.  Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy.

Authors:  Federica Pinna; Andrea Fiorillo; Massimo Tusconi; Beatrice Guiso; Bernardo Carpiniello
Journal:  Int J Ment Health Syst       Date:  2015-10-31

7.  Multilevel analysis of the determinants of the global assessment of functioning in an inpatient population.

Authors:  Karen A Urbanoski; Cecile Henderson; Saulo Castel
Journal:  BMC Psychiatry       Date:  2014-03-04       Impact factor: 3.630

8.  Clinical state tracking in serious mental illness through computational analysis of speech.

Authors:  Armen C Arevian; Daniel Bone; Nikolaos Malandrakis; Victor R Martinez; Kenneth B Wells; David J Miklowitz; Shrikanth Narayanan
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.